Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from Idexx Laboratories ( (IDXX) ) is now available.
IDEXX Laboratories has approved a Nonqualified Deferred Compensation Plan allowing select management and high-earning employees to defer parts of their compensation. The Plan provides flexibility in deferral options and includes provisions for discretionary company contributions, promising potential benefits for both the company and its participants.
More about Idexx Laboratories
IDEXX Laboratories, Inc. operates in the healthcare industry, specializing in veterinary diagnostics and information technology solutions. The company focuses on providing innovative products and services for the animal health, water testing, and dairy markets.
YTD Price Performance: -21.25%
Average Trading Volume: 614,497
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $35.79B
For a thorough assessment of IDXX stock, go to TipRanks’ Stock Analysis page.
